Founded in 2015
Genomill Health is a precision diagnostics company with a mission to disrupt the use of molecular diagnostic tests – liquid biopsies and beyond. Genomill wants to harness the use of the Next-Generation-Sequencing in diagnostics to the next level with our novel patented Geno1® sample preparation technology, enabling unprecedented improvements in performance and scalability.
Genomill’s Geno1® technology is a unique combination of molecular biology, robotics, next-generation DNA sequencing and artificial intelligence.
It truly provides means for unprecedented scaling of liquid biopsies and beyond by tackling the main drivers: cost, accuracy, turn-around-time and scalability